UBS Knock-Out ABT/ DE000UK0ZVT4 /
2024-11-08 7:31:21 PM | Chg.+0.160 | Bid9:55:14 PM | Ask9:55:14 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.660EUR | +3.56% | - Bid Size: - |
- Ask Size: - |
Abbott Laboratories | 67.2008 USD | 2078-12-31 | Call |
GlobeNewswire
08-06
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06-06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer